Clarksburg, MD, United States of America

Ashok Kumar Gupta

This inventor holds 22 USPTO granted patents and 8 published patent applications and 3 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Bristol-Myers Squibb Compnay, Innate Pharma, Medimmune Limited. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashok Kumar Gupta. Retrieved from https://idiyas.com/inventor/ashok-kumar-gupta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 8)

% Patents Active = 95.5

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 15

Forward Citations = 490(Granted Patents)

Location History:

Plainsboro, NJ (US) (2015 - 2019)
Clarksburg, MD (US) (2017 - 2020)

Company Filing History:

21 out of 3,745

Bristol-Myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Cancer Immunotherapy

PD-1

PD-L1

Antibodies

Combination Therapy

Anti-KIR

Anti-CTLA-4

Multiple Myeloma

Signaling Disruption

Tumor Treatment

Immune Response

Therapeutic Antibodies

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686716 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-07-21),

2. 12624107 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-05-12),

3. 12590154 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-03-31),

4. 12209126 - Treatment of cancer (2025-01-28),

5. 10688180 - Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer (2020-06-23),

6. 10604575 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-31),

7. 10584170 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-10),

8. 10577423 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-03),

9. 10494433 - Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma (2019-12-03),

10. 10323093 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-18),

11. 10323092 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-18),

12. 10316091 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-11),

13. 10316090 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-11),

14. 10308714 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-04),

15. 10266596 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-04-23),

Title: Ashok Kumar Gupta - Innovator from Clarksburg, MD

Introduction: Ashok Kumar Gupta is a renowned inventor hailing from Clarksburg, MD, known for his groundbreaking contributions to various fields.

Latest Patents: Ashok Kumar Gupta holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Gupta has worked with leading research institutions and companies, consistently pushing the boundaries of technology and science. His inventions have revolutionized the way we approach everyday challenges.

Collaborations: Gupta has collaborated with top universities and multinational corporations to bring his inventions to life. His ability to work across disciplines has led to the development of cutting-edge solutions that have a lasting impact.

Conclusion: Ashok Kumar Gupta's passion for innovation and his relentless pursuit of excellence make him a standout figure in the world of inventors. His work continues to inspire future generations to think outside the box and create a better tomorrow.

Profile summary based on public USPTO records.